Delivery Order SPE2DB22D3004-SPE2DB26FQ90D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,012.85 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,578.19 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine-Codeine 50-300 tablets (100 count) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count) with a ceiling value of $1,653.11. This competitive, non-set-aside award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,394.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg in 100-count units. This non-set-aside contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,550.42 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This firm fixed price delivery order, with an ultimate completion date of October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- The Defense Logistics Agency awarded a delivery order valued at $1,714.19 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) with a firm fixed price and completion date of August 27, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. The...
- The Defense Logistics Agency awarded a $1,043.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive award, issued without set-aside designation, is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,722.57 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (500 count). This firm fixed price, non-set-aside contract is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the company's broader...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ90DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,363.31 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count). This firm fixed-price, competitively awarded delivery order is expected to be completed by November 7, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract includes no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to military and veteran healthcare systems. The parent indefinite delivery contract enables the company to furnish diverse pharmaceutical products including specialty medications, generic and brand-name drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/6/25 |